Chihiro Mitsui

550 total citations
23 papers, 256 citations indexed

About

Chihiro Mitsui is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Pharmacology. According to data from OpenAlex, Chihiro Mitsui has authored 23 papers receiving a total of 256 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Physiology, 13 papers in Pulmonary and Respiratory Medicine and 6 papers in Pharmacology. Recurrent topics in Chihiro Mitsui's work include Asthma and respiratory diseases (19 papers), Respiratory and Cough-Related Research (10 papers) and Drug-Induced Adverse Reactions (5 papers). Chihiro Mitsui is often cited by papers focused on Asthma and respiratory diseases (19 papers), Respiratory and Cough-Related Research (10 papers) and Drug-Induced Adverse Reactions (5 papers). Chihiro Mitsui collaborates with scholars based in Japan. Chihiro Mitsui's co-authors include Kiyoshi Sekiya, Masami Taniguchi, Yuma Fukutomi, Hiroaki Hayashi, Takahiro Tsuburai, Keiichi Kajiwara, Kentaro Watai, Yosuke Kamide, Haruhisa Mita and Kazuo Akiyama and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Journal of Allergy and Clinical Immunology and The Journal of Allergy and Clinical Immunology In Practice.

In The Last Decade

Chihiro Mitsui

19 papers receiving 249 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chihiro Mitsui Japan 8 186 120 94 74 46 23 256
Jillian C. Bensko United States 9 304 1.6× 132 1.1× 139 1.5× 184 2.5× 139 3.0× 16 407
J.L. Rodriguez-Bada Spain 7 170 0.9× 33 0.3× 250 2.7× 158 2.1× 8 0.2× 18 339
Bassam Mahboub United Arab Emirates 7 109 0.6× 77 0.6× 48 0.5× 3 0.0× 3 0.1× 13 179
Autumn Guyer United States 8 47 0.3× 23 0.2× 120 1.3× 180 2.4× 16 248
Yasutoshi Sakamoto Japan 9 34 0.2× 51 0.4× 20 0.2× 7 0.1× 24 0.5× 25 174
Rahul Shrimanker United Kingdom 7 115 0.6× 96 0.8× 16 0.2× 5 0.1× 3 0.1× 27 152
Azmi Lale Türkiye 7 29 0.2× 36 0.3× 14 0.1× 6 0.1× 26 0.6× 17 166
Maximiliano Gómez Argentina 6 56 0.3× 12 0.1× 60 0.6× 37 0.5× 11 155
A. Padial Spain 9 69 0.4× 30 0.3× 217 2.3× 370 5.0× 15 436
Karin Förster Germany 4 52 0.3× 66 0.6× 3 0.0× 39 0.5× 1 0.0× 5 178

Countries citing papers authored by Chihiro Mitsui

Since Specialization
Citations

This map shows the geographic impact of Chihiro Mitsui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chihiro Mitsui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chihiro Mitsui more than expected).

Fields of papers citing papers by Chihiro Mitsui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chihiro Mitsui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chihiro Mitsui. The network helps show where Chihiro Mitsui may publish in the future.

Co-authorship network of co-authors of Chihiro Mitsui

This figure shows the co-authorship network connecting the top 25 collaborators of Chihiro Mitsui. A scholar is included among the top collaborators of Chihiro Mitsui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chihiro Mitsui. Chihiro Mitsui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hayashi, Hiroaki, Yuma Fukutomi, Chihiro Mitsui, et al.. (2023). Omalizumab ameliorates extrarespiratory symptoms in patients with aspirin-exacerbated respiratory disease. Journal of Allergy and Clinical Immunology. 151(6). 1667–1672.e2. 7 indexed citations
2.
Hayashi, Hiroaki, Yuma Fukutomi, Chihiro Mitsui, et al.. (2021). Efficacy of Omalizumab against Aspirin-hypersensitivity and Overproduction of Cysteinyl Leukotrienes in Aspirin-exacerbated Respiratory Disease: A Randomized Trial. Journal of Allergy and Clinical Immunology. 147(2). AB56–AB56. 1 indexed citations
3.
Hayashi, Hiroaki, Yuma Fukutomi, Chihiro Mitsui, et al.. (2020). Omalizumab for Aspirin Hypersensitivity and Leukotriene Overproduction in Aspirin-exacerbated Respiratory Disease. A Randomized Controlled Trial. American Journal of Respiratory and Critical Care Medicine. 201(12). 1488–1498. 68 indexed citations
4.
Taniguchi, Masami, Chihiro Mitsui, Hiroaki Hayashi, et al.. (2019). Aspirin-exacerbated respiratory disease (AERD): Current understanding of AERD. Allergology International. 68(3). 289–295. 46 indexed citations
5.
Kamide, Yosuke, Takahiro Tsuburai, Kentaro Watai, et al.. (2017). Exhaled Nitric Oxide Concentration Measured By NO Breath® Correlate with Asthma Severity. Journal of Allergy and Clinical Immunology. 139(2). AB200–AB200. 1 indexed citations
6.
Hayashi, Hiroaki, Yuma Fukutomi, Chihiro Mitsui, et al.. (2017). Smoking Cessation as a Possible Risk Factor for the Development of Aspirin-Exacerbated Respiratory Disease in Smokers. The Journal of Allergy and Clinical Immunology In Practice. 6(1). 116–125.e3. 13 indexed citations
7.
8.
Tsuburai, Takahiro, Yasuhiro Tomita, Yuto Hamada, et al.. (2017). DIFFERENCES IN FRACTION OF EXHALED NITRIC OXIDE VALUES MEASURED BY TWO HAND-HELDED ANALYZERS (NObreath® AND NIOX Vero®).. PubMed. 66(3). 204–208. 2 indexed citations
9.
Mitsui, Chihiro, Keiichi Kajiwara, Hiroaki Hayashi, et al.. (2016). P-Selectin is a Key Molecule Underlying the Pathophysiology of Aspirin- Exacerbated Respiratory Disease. 1(1). 1–5.
10.
Mitsui, Chihiro. (2016). Platelet activation markers overexpressed specifically in aspirin exacerbated respiratory disease. 1 indexed citations
11.
Mitsui, Chihiro, Emiko Ono, Keiichi Kajiwara, et al.. (2016). Is There Any Basophil Activation in Peripheral Blood in AERD Patients?. Journal of Allergy and Clinical Immunology. 137(2). AB107–AB107. 1 indexed citations
12.
Kamide, Yosuke, Tamotsu Ishizuka, Hiroaki Hayashi, et al.. (2016). Acidic Conditions Regulate Mast Cell Migration and Fc Epsilon RI–Mediated Cytokine Production. Journal of Allergy and Clinical Immunology. 137(2). AB75–AB75.
13.
Mitsui, Chihiro, Keiichi Kajiwara, Hiroaki Hayashi, et al.. (2015). Platelet activation markers overexpressed specifically in patients with aspirin-exacerbated respiratory disease. Journal of Allergy and Clinical Immunology. 137(2). 400–411. 57 indexed citations
14.
Mori, Akio, Takayuki Ohtomo, Jun Itoh, et al.. (2015). Development and treatment of steroid resistant asthma model by adoptive transfer of murine helper t cell clones. World Allergy Organization Journal. 8. A3–A3. 1 indexed citations
15.
Takahashi, Kentaro, Masami Taniguchi, Yuma Fukutomi, et al.. (2014). Oral Mite Anaphylaxis Caused by Mite-Contaminated Okonomiyaki/Pancake-Mix in Japan: 8 Case Reports and a Review of 28 Reported Cases. Allergology International. 63(1). 51–56. 28 indexed citations
16.
Shirai, Toshihiro, et al.. (2014). Anaphylaxis caused by tipepidine hibenzate, a central antitussive drug. Respirology Case Reports. 3(1). 3–5. 1 indexed citations
17.
Sekiya, Kiyoshi, Masami Taniguchi, Yuma Fukutomi, et al.. (2012). Persistent Airflow Obstruction in Young Adult Asthma Patients. Allergology International. 61(1). 143–148. 2 indexed citations
18.
Tsurikisawa, Naomi, Chiyako Oshikata, Takahiro Tsuburai, et al.. (2012). Markers for Step-Down of Inhaled Corticosteroid Therapy in Adult Asthmatics. Allergology International. 61(3). 419–429. 13 indexed citations
19.
Sekiya, Kiyoshi, Kentaro Watai, Masami Taniguchi, et al.. (2011). Latex Anaphylaxis Caused by a Swan-Ganz Catheter. Internal Medicine. 50(4). 355–357.
20.
Sekiya, Kiyoshi, Masami Taniguchi, Yuma Fukutomi, et al.. (2011). Actual Control State of Intermittent Asthma Classified on the Basis of Subjective Symptoms. Internal Medicine. 50(15). 1545–1551. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jillian C. Bensko Breakdown of academic impact, for papers by J.L. Rodriguez-Bada Breakdown of academic impact, for papers by Bassam Mahboub Breakdown of academic impact, for papers by Autumn Guyer Breakdown of academic impact, for papers by Yasutoshi Sakamoto Breakdown of academic impact, for papers by Rahul Shrimanker Breakdown of academic impact, for papers by Azmi Lale Breakdown of academic impact, for papers by Maximiliano Gómez Breakdown of academic impact, for papers by A. Padial Breakdown of academic impact, for papers by Karin Förster
Rankless by CCL
2026